What the Board Should Demand on Silent Technology Exposure

The Board's Checklist for Silent Technology Exposure in Legacy Wordings

A board that accepts management's assurance without asking for the underlying evidence is accepting a description of good intentions, not proof of control. Silent technology exposure in legacy wordings is exactly the kind of risk where that gap between assurance and evidence tends to hide for years. This piece sets out the specific checklist a board should work through before tolerating this exposure any further.

What should the board demand before tolerating silent technology exposure in legacy wordings?

Documented evidence of a prioritized backlog, a named owner, and measurable progress, not a general statement that the topic is on management's radar.

Boards routinely hear that a given emerging risk is "being monitored" or "on the agenda," language that sounds reassuring but commits management to nothing specific. For an exposure with this much capital and reputational consequence, that level of vagueness is not an acceptable substitute for a documented plan. The board's job here is to convert a soft assurance into a specific, checkable set of deliverables.

Why is "we're aware of it" not the same as "we're managing it"?

Because awareness requires no action, no accountability, and no measurable progress, while management requires all three.

An organization can be genuinely aware of silent technology exposure in legacy wordings for years without doing anything concrete about it, simply because awareness alone does not force a decision about priority or resourcing. What the board should demand before tolerating any comparable emerging exposure makes the same distinction on the AI liability side: an organization that can describe a risk is in a very different position from one that can produce a register, an owner, and a progress metric for it.

What specific evidence should the board require from management?

A joint presentation from legal, underwriting, and finance, each contributing the piece of evidence only they can provide.

What should legal and underwriting jointly present?

A prioritized list of legacy wordings by age and premium concentration, plus the current review status of the highest-priority segment.

Legal alone can describe wording ambiguity in the abstract, but pairing legal with underwriting produces something more useful: a ranked list showing exactly where the largest, most urgent exposure sits, and what has actually been done about it so far. Reinsurance Contract Clause Analyzer AI Agent can help generate exactly this kind of ranked, evidence-based list directly from the treaty wordings themselves, rather than relying on anecdotal knowledge of which wordings are old or risky.

What should the CFO present alongside them?

The capital charge currently held against unreviewed wording risk, and a clear picture of how that charge is expected to move as review progresses.

Without this figure, the board has no way to judge whether the remediation effort is actually worth prioritizing against other capital initiatives competing for the same resources. With it, the board can hold management accountable to a specific, trackable financial outcome rather than a vague sense that things are improving.

How does the Lloyd's precedent set a governance benchmark boards should expect?

It shows that a phased, milestone-driven review, with clear oversight, is genuinely achievable at scale, which sets a fair benchmark for what an individual organization should be able to produce internally.

The Intelligent Insurer's reporting on the Lloyd's mandate confirms it was rolled out with defined phases, a working group structure, and a formal market oversight plan tracking compliance. That was a market-wide effort involving hundreds of managing agents, and it still produced measurable, phased progress with clear milestones. A single organization, with a far smaller scope to manage, has no excuse for producing less rigor internally than the market achieved collectively.

What questions expose whether this is genuinely being tracked?

Ask for the specific percentage of premium behind reviewed wordings, since a vague or unavailable answer to that question is itself diagnostic.

A board that asks these four questions and gets vague answers to all of them has learned something important about how seriously this risk is actually being managed.

What reporting cadence should the board institutionalize?

A quarterly update covering backlog status, premium reviewed, and capital charge movement, held to the same rigor as any other capital-relevant board reporting item.

Treating this as a quarterly, quantified reporting item, rather than an annual mention inside a broader emerging-risks discussion, keeps management accountable to steady, visible progress rather than allowing the initiative to quietly stall between infrequent check-ins.

What red flags should concern a board risk committee?

No named owner, no documented backlog, or a backlog that has shown no measurable movement since it was first reported.

Any of these signs, on their own, is worth a direct follow-up question at the next board meeting. Together, they indicate the organization has acknowledged the risk without actually building the operating discipline needed to manage it, a distinction covered further from the operational side in turning silent technology exposure in legacy wordings into a measurable management process.

What should the board require happen before the next renewal season?

A completed review of the highest-priority wording segment and a documented plan for the next phase, reported with specific findings rather than a general status update.

This is an achievable, concrete deadline, not an aspirational one, since the data needed to prioritize and begin the review already exists inside underwriting and legal systems today. What has typically been missing is board-level insistence on seeing the evidence, which is the one lever a board can pull directly, regardless of how the rest of the organization has structured this work internally.

How should the board treat wordings inherited through M&A or portfolio acquisitions?

The board should require that any acquired portfolio be added to the wording review backlog immediately, rather than assuming standard transaction due diligence already covered this specific exposure.

Acquisitions and portfolio transfers are a common way this exposure quietly re-enters an otherwise well-managed book, since most transaction due diligence checklists do not yet include a dedicated line item for silent technology exposure. A board approving any future acquisition or portfolio transfer should explicitly ask whether the target's legacy wordings have been assessed for this risk, and should expect the answer to feed directly into the purchase price or into a post-acquisition remediation commitment. Treating this as a standing question in every future transaction, not a one-time cleanup exercise, prevents the same gap from reopening every time the organization grows through acquisition rather than organically.

What value does third-party assurance add beyond management's own reporting?

Independent verification gives the board a source of confidence that does not depend entirely on trusting management's self-assessment of its own progress.

A specialist reinsurance advisory firm, an actuarial consultant, or an internal audit function can be asked to independently sample the wording review backlog against actual treaty documents, confirming that reported progress reflects real, completed reviews rather than administrative activity that looks complete on a status report. This is a natural extension of relationships many organizations already have in place through existing audit and actuarial engagements, rather than a request for an entirely new advisory relationship. A board that pairs strong internal quarterly reporting with periodic independent verification is in the strongest position to demonstrate genuine control of this risk to regulators, rating agencies, and shareholders, rather than relying on management's word alone.

How should the board handle disagreement between the CUO and CFO on prioritization?

The board should require both to present their reasoning together and resolve genuine disagreement quickly, rather than letting an unresolved disagreement stall the initiative indefinitely.

A CUO focused on wording risk and a CFO focused on capital relief may reasonably disagree about which segment of the book deserves review first, particularly when the data supporting either view is still incomplete in the early stages of the process. The board's role here is not to make the technical prioritization call itself, but to insist that both perspectives are presented together, with a specific recommendation, and to set a deadline by which a joint decision must be reached. An unresolved disagreement that is allowed to persist quietly for multiple quarters is functionally the same as no decision being made at all, and it should be treated by the board as its own kind of red flag.

A board that insists on documented evidence, rather than general reassurance, is the single most effective lever available for closing silent technology exposure before it becomes a costly, public coverage dispute. The organizations whose boards ask for the register, the owner, and the number will be the ones actually ahead of this risk when it is finally tested by a real claim.

Sources

• Intelligent Insurer, "Lloyd's takes tough stand on 'silent cyber' in new mandate"
• Markel, "Addressing Non-Affirmative Cyber"